1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant OutcomesBacterial Infections and Mycoses, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Stomatognathic Diseases, Urogenital Diseases, candidiasis, female reproductive system disorder, fungal infectious disease, mouth disorder, oral candidiasis, vaginal disorder, vaginitis, vulvar disease, vulvitis, vulvovaginal candidiasis, vulvovaginitisRecruitingNot stated2026-09-23NCT05908682